Product Code: RP-ID-10013192 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013192
Market Overview:
Global Hepatitis Diagnostics Test Market Size Study, By Test (Blood Test, Imaging Test, and liver Biopsy), and Regional Forecasts, 2017-2025
Global Hepatitis Diagnostics Test industry valued approximately USD 3.6 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.8 % over the forecast period 2017-2025. Several factors such as increasing awareness for monitoring and screening procedures, increasing prevalence of hepatitis and growing demand for diagnostic techniques are likely to force the global market over the anticipated period.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Test Type:
 Blood Test
 Imaging Test
 Liver Biopsy
Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Abbott Laboratories, Danaher Corporation, F. Hoffmann Roche, MedMira, Inc., DiaSorin S.p.A, Siemens Ag, and Hologic, Inc. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Hepatitis Diagnostics Test Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
MedMira Inc
Qaigen Inc
Diasorin S.p.A
Hologic Inc
Bio-Rad Laboratories Inc
bioMeriuex
Beckman Coulter Inc (Danaher Corporation)
F. Hoffmann Roche
Related Reports
Proof of Quality & Reliability
